Drug details
Qmiiz-ODT (meloxicam orally disintegrating tablets)
type of NSAIDs
QMIIZ ODT (meloxicam) is a nonsteroidal anti-inflammatory drug indicated for osteoarthritis (OA) in adults, rheumatoid arthritis (RA) in adults, and juvenile rheumatoid arthritis (JRA) pauciarticular and polyarticular course, in pediatric patients who weigh greater than or equal to 60 kg.
The drug is often used to treat Arthritis .
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- nausea,
- upper stomach pain,
- loss of appetite,
- itching,
- dark urine,
- fever,
- pale skin,
- lightheadedness,
- shortness of breath,
- cold hands and feet,
- tiredness,
- clay-colored stools,
- yellowing of the skin or eyes (jaundice),
- flu-like symptoms,
- unusual tiredness,
- sore throat,
- burning eyes,
- skin pain,
- red or purple skin rash with blistering and peeling,
- little or no urination,
- slurred speech,
- bloody or tarry stools,
- coughing up blood,
- vomit that looks like coffee grounds,
- swelling in your feet or ankles, and
- shortness of breath
- sudden numbness or weakness on one side of the body,
- swelling or rapid weight gain,
- chest pain spreading to your jaw or shoulder,
- leg swelling,
- first sign of any skin rash (no matter how mild),
The following drugs are related to Qmiiz-ODT, either as a replacement or used together:
- Humira (adalimumab injection solution for subcutaneous administration)
- Celebrex (celecoxib)
- Voltaren (diclofenac sodium)
- Voltaren XR (diclofenac sodium extended-release tablets)
- Voltaren Gel (diclofenac sodium gel)
- Feldene (piroxicam)
- Remicade (infliximab)
- Mobic (meloxicam)
- Relafen (nabumetone)
- Naprosyn, Anaprox, Anaprox DS (naproxen)
- Xeljanz (tofacitinib tablets)